PDF-associated symptoms) were treated with intravenous naloxone (0.4 mg ev
Author : min-jolicoeur | Published Date : 2015-10-01
1 Springer pruritus varies from oral antihistaminic drugs to liver transplantation Central opioidergic tone is one of the various mechanisms proposed in the genesis
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "associated symptoms) were treated with i..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
associated symptoms) were treated with intravenous naloxone (0.4 mg ev: Transcript
1 Springer pruritus varies from oral antihistaminic drugs to liver transplantation Central opioidergic tone is one of the various mechanisms proposed in the genesis of pruritus Opioid antagonists. Emergency Medical Responders and. Law Enforcement. There may be a title here that come from the foundation. Objectives . In this slide set, you will learn:. What naloxone (. Narcan. ) is. How it works when administered to a person who has overdosed. Narcan. ) Induced Pulmonary Edema. John Cunha, DO, FACOEP. Holy Cross Hospital. Oakland Park EMS Medical Director. Naloxone (. Narcan. ) Use. Used to reverse the respiratory depression effects of opioids. Infusions For Postoperative Pain Management. Opioids are the most commonly used medications for perioperative pan control.. Recent studies evaluated the efficacy of . nonopioids. , such as ketamine , . Objectives . Background & statutes . Define naloxone . Routes of administration . Training requirements . Immunity . The Opioid Problem: . Lethal Drug. overdose. is the leading cause of . accidental death in America . Rebecca McDonald. National Addiction . Centre. King’s College London. Declarations. RM has undertaken an unpaid student industry placement with . Mundipharma. Research Ltd., with focus on the analysis of naloxone nasal spray formulations. Findings from a linked dataset. Dan Galanis, Ph.D.. Epidemiologist. EMS & Injury Prevention System Branch. Hawaii Department of Health. 2. Overview of presentation. Part 1: EMS administration of naloxone (2012-2016). IMPD Southwest District Narcan Pilot Project. Objectives. Overview of the problem . Discuss the basics of opioids. What are opioids?. Illicit and Prescription. Educate on recognition of opioid overdose. Adapted from: . Community . Access . Naloxone Is . there a downside. ?. . Michael . W. Dailey, MD . Albancy. Medical Center. Motor vehicle traffic, poisoning, drug poisoning, and unintentional drug poisoning death rates: United States, 1999--2010. October 24. th. ,. . 2016. Sarah Ruiz, . MSW. , . Naloxone Pilot Program, Massachusetts Department of Public Health. Alexander Walley,. MD, MSc, Medical Director, MDPH Opioid Overdose Prevention Pilot Program. Promoting Overdose Prevention and Naloxone Icebreaker Name Where you are from How much experience do you have giving community presentations? Your favorite topic for a presentation, your least favorite topic (that you have been asked to do, in public) First Responder Naloxone Grant FY18 Webinar Sarah Ruiz, Program Director Dr. Alex Walley, Medical Director Brittni Reilly, Program Coordinator Monday 9/25/2017 Audio: 1-877-838-7060 Agenda Review of Current Statistics / Trends NALOXONE (. Narcan. ®). Developed in the 1960s. Increased opioid use and abuse. Greater . variety of available opioids . Increased demand for naloxone. Opioid . competitive antagonist. Emergent overdose treatment in hospital and . Admixtures, and Rate-of-Flow. Calculations. By . Ali . Khidher. . Alobaidy. Injections are sterile pharmaceutical solutions or suspensions of a drug substance in an . aqueous or . nonaqueous. vehicle. . Trainer Name. location AND DATE. Learning objectives. By the end of the presentation, participants will:. Understand requirements of the Community-Based Naloxone Access Program Standing Order. Know what naloxone is and how to store, track and administer it.
Download Document
Here is the link to download the presentation.
"associated symptoms) were treated with intravenous naloxone (0.4 mg ev"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents